AdaptHealth (NASDAQ:AHCO – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.
AHCO has been the topic of several other research reports. Weiss Ratings restated a “sell (d+)” rating on shares of AdaptHealth in a report on Wednesday, October 8th. Zacks Research cut AdaptHealth from a “hold” rating to a “strong sell” rating in a report on Friday, September 19th. Five research analysts have rated the stock with a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, AdaptHealth presently has an average rating of “Hold” and an average price target of $13.40.
Read Our Latest Analysis on AHCO
AdaptHealth Stock Performance
Insider Transactions at AdaptHealth
In related news, Director David Solomon Williams III sold 8,200 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $9.73, for a total value of $79,786.00. Following the transaction, the director owned 50,045 shares in the company, valued at $486,937.85. This trade represents a 14.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.55% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On AdaptHealth
Hedge funds have recently added to or reduced their stakes in the company. AlphaQuest LLC boosted its holdings in AdaptHealth by 275.7% in the second quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock valued at $37,000 after acquiring an additional 2,892 shares during the last quarter. Assetmark Inc. boosted its holdings in AdaptHealth by 87.6% in the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock valued at $52,000 after acquiring an additional 2,581 shares during the last quarter. GAMMA Investing LLC boosted its holdings in AdaptHealth by 175.2% in the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock valued at $81,000 after acquiring an additional 4,758 shares during the last quarter. Brooklyn Investment Group boosted its holdings in AdaptHealth by 531.8% in the first quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock valued at $82,000 after acquiring an additional 6,366 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its holdings in AdaptHealth by 318.0% in the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after acquiring an additional 7,297 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.
AdaptHealth Company Profile
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
See Also
- Five stocks we like better than AdaptHealth
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- 3 REITs to Buy and Hold for the Long Term
- Could Target’s Week of Discounts Come Full Circle for Investors?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.